Doctor profile · Federal record
Dr. Tanya Bhattacharya, MD
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Crest Hill, IL
- NPI 1902284078
- Accepts Medicare
- MIPS 83.3 / 100 · 2023
- 11 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
2051 Plainfield RD
Crest Hill, IL 604031865
(815) 741-4343
fax (815) 741-8660 - Additional location
-
1520 Bond St
Naperville, IL 605632358
(630) 357-7536
fax (630) 904-0413 - Mailing address
-
801 York St
Manitowoc, WI 542204630
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- March 8, 2021
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Illinois #036149813 · Florida #ME129310
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902284078. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,701
Distinct HCPCS
10
Medicare allowed
$109,776
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 444 | 70 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 368 | 263 | $93 | |
11102 |
Biopsy of related skin growth, first growth | 183 | 159 | $101 | |
17000 |
Destruction of precancer skin growth, 1 growth | 165 | 105 | $55 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 125 | 97 | $59 | |
17110 |
Destruction of skin growth, 1-14 growths | 95 | 81 | $118 | |
96900 |
Application of ultraviolet light to skin | 67 | 11 | $26 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 59 | 59 | $116 | |
11103 |
Biopsy of related skin growth, each additional growth | 57 | 43 | $52 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | 19 | $1 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 193. This provider delivers 8.8× the peer median.Open Payments
Industry payments received
All-time total
$586
Transactions
30
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 13 | $169.04 | |
| GENZYME CORPORATION | 4 | $135.48 | |
| Dermavant Sciences, Inc. | 3 | $69.94 | |
| Lilly USA, LLC | 3 | $63.78 | |
| PFIZER INC. | 2 | $43.80 | |
| Novartis Pharmaceuticals Corporation | 2 | $33.42 | |
| Incyte Corporation | 1 | $29.62 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21.58 | |
| Janssen Biotech, Inc. | 1 | $19.81 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
693
Patients
402
Total drug cost
$67,376
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 125 | 88 | $1,214 |
| Ketoconazole | Generic | 123 | 46 | $2,157 |
| Triamcinolone Acetonide | Generic | 84 | 62 | $693 |
| Clobetasol Propionate | Generic | 81 | 51 | $5,597 |
| Doxycycline Hyclate | Generic | 50 | 39 | $2,553 |
| Betamethasone Dipropionate | Generic | 38 | 26 | $1,708 |
| Metronidazole | Generic | 32 | 0 | $2,096 |
| Hydrocortisone | Generic | 28 | 27 | $184 |
| Cephalexin | Generic | 27 | 23 | $222 |
| Mometasone Furoate | Generic | 26 | 18 | $528 |
Frequently asked questions
What is Dr. Tanya Bhattacharya's medical specialty?
Dr. Tanya Bhattacharya practices Dermatology Physician in Crest Hill, IL.
Where does Dr. Tanya Bhattacharya practice?
Dr. Tanya Bhattacharya practices at 2051 Plainfield RD, Crest Hill, IL 604031865. Office phone: 8157414343.
What is Dr. Tanya Bhattacharya's NPI?
Dr. Tanya Bhattacharya's National Provider Identifier (NPI) is 1902284078, issued by NPPES.
Does Dr. Tanya Bhattacharya accept Medicare assignment?
Yes. Dr. Tanya Bhattacharya accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tanya Bhattacharya commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.